Synopsis of recent research by authors named "DeQiu Zhu"
- Deqiu Zhu's recent research primarily focuses on pharmacovigilance and drug-related problems, utilizing large databases such as the FDA Adverse Event Reporting System (FAERS) to investigate drug-drug interactions (DDIs) and assess safety profiles of pharmaceuticals in real-world settings.
- Key findings highlight the potential risks associated with concomitant use of colchicine and statins leading to rhabdomyolysis, as well as the analysis of adverse events linked to teprotumumab for treating thyroid eye disease.
- Zhu's studies also address important health issues such as sarcopenia in type 2 diabetes patients related to sodium-glucose transporter 2 inhibitors, and the role of clinical pharmacists in managing drug-related problems among elderly patients with ischemic stroke in China.
